Johnson & Johnson Chairman and CEO William Weldon is scheduled to testify at today’s hearing held by the The House Committee on Oversight and Government Reform. Weldon is expected to answer questions about J&J/McNeil Consumer Healthcare’s April 30, 2010, recall of more than 135 million bottles of infants’ and children’s medication. Products were recalled because of the possibility of the medication containing too much of the active ingredient, substandard inactive ingredients, or particles.
Weldon will also be asked to explain the circumstances surrounding what the committee dubbed the “phantom recall” of Motrin in 2008, in which J&J allegedly hired contractors to pose as customers and buy a certain type of adult Motrin in order to remove the product from store shelves. The phantom recall came to light in documents produced during the committee’s first hearing on May 27, 2010.
Weldon was not present for the May hearing because of a scheduling conflict. Colleen Goggins, worldwide chairman of J&J’s consumer group, spoke to the committee in May in Weldon’s place. She is also expected to testify today.
Committee Chairman Edolphus “Ed” Towns also invited Joshua Sharfstein, principal deputy commissioner at the US Food and Drug Administration, to discuss the phantom recall at the hearing. Towns requested copies of all FDA documents regarding J&J’s 2008 Motrin recall, including all communication between employees of the agency and J&J from January 2009 to June 2009.
The hearing will begin at 10:00 a.m. ET and can be seen via webcast at http://oversight.house.gov.